Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2005-08-02
2010-06-22
Allen, Marianne P (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C530S387100
Reexamination Certificate
active
07740843
ABSTRACT:
Antibodies which are specific for human interleukin-4 and their use in the treatment of IL-4 and/or IgE mediated diseases.
REFERENCES:
patent: 5705154 (1998-01-01), Dalie et al.
patent: 5914110 (1999-06-01), Holmes et al.
patent: 2002/0002132 (2002-01-01), Pluenneke
patent: 93/17106 (1993-09-01), None
patent: 2004/058797 (2004-07-01), None
Yau, et al., “Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies,” Biotechnology Advances 21:599-637 (2003).
Carballido Herrera José M.
De Vries Jan E.
Schwaerzler Christoph
Allen Marianne P
Lacourse Karen A.
Novartis AG
LandOfFree
Human monoclonal antibodies against human IL-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal antibodies against human IL-4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibodies against human IL-4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4169932